The DOI matches its Crossref record; 556 of the 558 references it cites were found in a registry or an index.
2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation
Open accessAbstract
Patients with atrial fibrillation and coronary artery disease . . . . . . . . .1647 Cardioversion in a NOAC-treated patient . . . . . . . . . . . . . . . . . . . . . . . .1651 AF patients presenting with acute stroke while on NOACs . . . . . . . .1652 NOACs in advanced age and frailty . . . . . . . . . . . .
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Such switch is very common in the hospital setting, mostly as part of periprocedural bridging [24].”
From Overall performance of a drug–drug interaction clinical decision support system: quantitative evaluation and end-user survey (2022) · cites this paper as [24]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 401–556 of 556
Genetically Elevated LDL Associates with Lower Risk of Intracerebral Hemorrhage
Falcone, G. J., Kirsch, E. P., Acosta, J., Noche, R. B., Leasure, A. C., Marini, S., Chung, J., Selim, M. H., Meschia, J. F., Brown, D. L., et al. (2020) · Annals of Neurology · doi:10.1002/ana.25740 · Cited by 57
Tsai, C.-T., Liao, J., Chiang, C., Lin, Y., Chang, S., Lo, L., Hu, Y., Tuan, T., Chung, F., Chao, T., et al. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.6424 · Cited by 57
Self-citationThe prognosis of acute symptomatic seizures after ischaemic stroke
Leung, T. W. H., Leung, H., Soo, Y. O. Y., Mok, V., & Wong, K. S. (2016) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2015-311849 · Cited by 56
Rush, K. L., Burton, L., Schaab, K., & Lukey, A. (2019) · European Journal of Cardiovascular Nursing · doi:10.1177/1474515119845198 · Cited by 55
Pham, P., Schmidt, S., Lesko, L. J., Lip, G. Y. H., & Brown, J. D. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.3593 · Cited by 55
Self-citationHarenberg, J., Schreiner, R., Hetjens, S., & Weiß, C. (2018) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0038-1668098 · Cited by 54
Pokorney, S. D., Black‐Maier, E., Hellkamp, A. S., Friedman, D. J., Vemulapalli, S., Granger, C. B., Thomas, L. E., Peterson, E. D., & Piccini, J. P. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.01.019 · Cited by 54
Kubitza, D., Becka, M., Roth, A., & Mueck, W. (2012) · Journal of International Medical Research · doi:10.1177/030006051204000508 · Cited by 53
Noseworthy, P. A., Yao, X., Shah, N. D., & Gersh, B. J. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.04.026 · Cited by 53
Age Threshold for Ischemic Stroke Risk in Atrial Fibrillation
Kim, T., Yang, P., Yu, H. T., Jang, E., Uhm, J., Kim, J., Pak, H., Lee, M., Joung, B., & Lip, G. Y. H. (2018) · Stroke · doi:10.1161/strokeaha.118.021047 · Cited by 53
Self-citationAssociation of anticoagulant therapy with risk of dementia among patients with atrial fibrillation
Kim, D., Yang, P., Jang, E., Yu, H. T., Kim, T., Uhm, J., Kim, J., Sung, J., Pak, H., Lee, M., et al. (2020) · EP Europace · doi:10.1093/europace/euaa192 · Cited by 53
Self-citationDurães, A. R., Bitar, Y. D. S. L., Schonhofen, I. S., Travassos, K. S. O., Pereira, L. V., Filho, J. A. L., Neto, M. G., Aras, R., & Roever, L. (2020) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-020-00449-3 · Cited by 53
Thomas, K. L., Piccini, J. P., Liang, L., Fonarow, G. C., Yancy, C. W., Peterson, E. D., & Hernandez, A. F. (2013) · Journal of the American Heart Association · doi:10.1161/jaha.113.000200 · Cited by 52
The impact of body weight on rivaroxaban pharmacokinetics
Barsam, S. J., Patel, J. P., Roberts, L. N., Kavarthapu, V., Patel, R., Green, B., & Arya, R. (2017) · Research and Practice in Thrombosis and Haemostasis · doi:10.1002/rth2.12039 · Cited by 52
Regional Gastrointestinal Absorption of Apixaban in Healthy Subjects
Byon, W., Nepal, S., Schuster, A. E., Shenker, A., & Frost, C. E. (2018) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.1097 · Cited by 52
Søgaard, M., Skjøth, F., Jensen, M., Kjældgaard, J. N., Lip, G. Y. H., Larsen, T. B., & Nielsen, P. B. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.118.011358 · Cited by 52
Self-citationWang, C., Wu, V. C., Chang, K., Tu, H., Kuo, C., Huang, Y., Chu, P., Kuo, C.-C., & Chang, S. (2019) · European Heart Journal - Cardiovascular Pharmacotherapy · doi:10.1093/ehjcvp/pvz035 · Cited by 52
Outcomes associated with apixaban vs warfarin in patients with renal dysfunction
Hanni, C. M., Petrovitch, E. A., Ali, M. A., Gibson, W., Giuliano, C. A., Holzhausen, J. M., Makowski, C. T., Pallisco, A., Patel, N., Sutter, D. A., et al. (2020) · Blood Advances · doi:10.1182/bloodadvances.2019000972 · Cited by 52
Evaluation of regional gastrointestinal absorption of edoxaban using the enterion capsule
Parasrampuria, D. A., Kanamaru, T., Connor, A. L., Wilding, I. R., Ogata, K., Shimoto, Y., & Kunitada, S. (2015) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.540 · Cited by 51
Ischemic Stroke in an Obese Patient Receiving Dabigatran
Breuer, L., Ringwald, J., Schwab, S., & Köhrmann, M. (2013) · New England Journal of Medicine · doi:10.1056/nejmc1215900 · Cited by 51
Moore, K. T., Krook, M. A., Vaidyanathan, S., Sarich, T. C., Damaraju, C. V., & Fields, L. E. (2014) · Clinical Pharmacology in Drug Development · doi:10.1002/cpdd.123 · Cited by 50
Mendell, J., Lee, F., Chen, S., Worland, V., Shi, M., & Samama, M. M. (2013) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e3182970991 · Cited by 50
LaHaye, S. A., Gibbens, S. L., Ball, D. G. A., Day, A. G., Olesen, J. B., & Skanes, A. C. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs167 · Cited by 50
Drouet, L. O., Sollier, C. B. D., Steiner, T., & Purrucker, J. C. (2016) · International Journal of Stroke · doi:10.1177/1747493016659671 · Cited by 50
Kim, K., Lee, Y., Kim, T.-H., Uhm, J., Pak, H., Lee, M., & Joung, B. (2018) · Korean Circulation Journal · doi:10.4070/kcj.2017.0328 · Cited by 50
Self-citationKajy, M., Shokr, M., & Ramappa, P. (2019) · American Journal of Therapeutics · doi:10.1097/mjt.0000000000000937 · Cited by 50
Rodríguez, L. A. G., Martín‐Pérez, M., Vora, P., Roberts, L., Balabanova, Y., Brobert, G., Fatoba, S., Suzart‐Woischnik, K., Schaefer, B., & Ruigómez, A. (2019) · BMJ Open · doi:10.1136/bmjopen-2019-031341 · Cited by 50
Giugliano, R. P., Ruff, C. T., Rost, N. S., Silverman, S. B., Wiviott, S. D., Lowe, C., Deenadayalu, N., Murphy, S. A., Grip, L. T., Betcher, J., et al. (2014) · Stroke · doi:10.1161/strokeaha.114.006025 · Cited by 49
Nielsen, P. B., Skjøth, F., Søgaard, M., Kjældgaard, J. N., Lip, G. Y. H., & Larsen, T. B. (2019) · Stroke · doi:10.1161/strokeaha.118.023797 · Cited by 49
Self-citationGlobal Use of Idarucizumab in Clinical Practice: Outcomes of the RE-VECTO Surveillance Program
Fanikos, J. R., Murwin, D., Gruenenfelder, F. I., Tartakovsky, I. S., França, L. R., Reilly, P. A., Kermer, P., von Wowern, F., Lane, D. A., & Butcher, K. (2019) · Thrombosis and Haemostasis · doi:10.1055/s-0039-1695771 · Cited by 49
Self-citationDual Versus Triple Therapy for Atrial Fibrillation After Percutaneous Coronary Intervention
Khan, S. U., Osman, M., Khan, M. U., Khan, M. S., Zhao, D., Mamas, M. A., Savji, N., Al‐Abdouh, A., Hasan, R. K., & Michos, E. D. (2020) · Annals of Internal Medicine · doi:10.7326/m19-3763 · Cited by 49
Lee, H., Kim, H., Jung, J., Han, K., Lee, H., Park, J., Kim, H. M., Kim, Y.-J., & Ommen, S. R. (2019) · Stroke · doi:10.1161/strokeaha.119.026048 · Cited by 48
Hellwig, S., Grittner, U., Audebert, H. J., Endres, M., & Hæusler, K. G. (2017) · EP Europace · doi:10.1093/europace/eux087 · Cited by 47
Mizoguchi, T., Tanaka, K., Toyoda, Ḱ., Yoshimura, S., Itabashi, R., Takagi, M., Todo, K., Shiozawa, M., Yagita, Y., Yoshimoto, T., et al. (2020) · Stroke · doi:10.1161/strokeaha.119.028118 · Cited by 47
Gargiulo, G., Cannon, C. P., Gibson, C. M., Goette, A., Lópes, R. D., Oldgren, J., Korjian, S., Windecker, S., Esposito, G., Vranckx, P., et al. (2020) · European Heart Journal - Cardiovascular Pharmacotherapy · doi:10.1093/ehjcvp/pvaa116 · Cited by 47
Self-citationEmren, S. V., Şenöz, O., Bilgin, M., Beton, O., Aslan, A., Taşkın, U., Açıksarı, G., Asarcıklı, L. D., Çakır, H., Bekar, L., et al. (2017) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029617693940 · Cited by 46
Greenblatt, D. J., Patel, M. R., Harmatz, J. S., Nicholson, W. T., Rubino, C. M., & Chow, C. R. (2017) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.1040 · Cited by 46
Song, Y. J., Chang, M., Suzuki, A., Frost, R. J., Kelly, A. M., LaCreta, F. P., & Frost, C. E. (2016) · Clinical Therapeutics · doi:10.1016/j.clinthera.2016.05.004 · Cited by 45
Bhangu, J. S., King‐Kallimanis, B. L., Donoghue, O. A., Carroll, L., & Kenny, R. A. (2017) · PLoS ONE · doi:10.1371/journal.pone.0180997 · Cited by 45
Lane, D. A., Meyerhoff, J., Rohner, U., & Lip, G. Y. H. (2018) · Clinical Cardiology · doi:10.1002/clc.22971 · Cited by 45
Self-citationPreventing Stroke in Patients With Chronic Kidney Disease and Atrial Fibrillation
Reinecke, H., Engelbertz, C. M., & Schäbitz, W. (2013) · Stroke · doi:10.1161/strokeaha.113.001701 · Cited by 44
Self-citationvan Tuijl, J. H., van Raak, E. P. M., de Krom, M. C. T. F. M., Lodder, J., & Aldenkamp, A. P. (2011) · Seizure · doi:10.1016/j.seizure.2010.12.012 · Cited by 44
Caterina, R. D., & Camm, A. J. (2015) · EP Europace · doi:10.1093/europace/euv288 · Cited by 44
Self-citationDirect-acting oral anticoagulant drug level monitoring in clinical patient management
Rottenstreich, A., Zacks, N., Kleinstern, G., Raccah, B. H., Roth, B., Da’as, N., & Kalish, Y. (2018) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-018-1643-0 · Cited by 44
Chao, T., Chiang, C., Liao, J., Chen, T., Lip, G. Y. H., & Chen, S. (2019) · CHEST Journal · doi:10.1016/j.chest.2019.11.025 · Cited by 44
Self-citationBoriani, G., Ruff, C. T., Kuder, J., Shi, M., Lanz, H., Antman, E. M., D, E. B. M., & Giugliano, R. P. (2020) · Thrombosis and Haemostasis · doi:10.1055/s-0040-1716540 · Cited by 44
Self-citationHarrison, S. L., Fazio‐Eynullayeva, E., Lane, D. A., Underhill, P., & Lip, G. Y. H. (2020) · Journal of Arrhythmia · doi:10.1002/joa3.12458 · Cited by 44
Self-citationMiao, B., Sood, N. A., Bunz, T. J., & Coleman, C. I. (2020) · European Journal Of Haematology · doi:10.1111/ejh.13383 · Cited by 42
Noseworthy, P. A., Yao, X., Shah, N. D., & Gersh, B. J. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.02.005 · Cited by 41
Progress in the monitoring of direct oral anticoagulant therapy
Patel, J. P., Byrne, R., Patel, R., & Arya, R. (2019) · British Journal of Haematology · doi:10.1111/bjh.15756 · Cited by 41
Effect of famotidine on the pharmacokinetics of apixaban, an oral direct factor Xa inhibitor
Upreti, V. V., Song, Wang, Byon, Boyd, Pursley, LaCreta, & Frost (2013) · Clinical Pharmacology Advances and Applications · doi:10.2147/cpaa.s41999 · Cited by 40
Effect of New Oral Anticoagulants on Prescribing Practices for Atrial Fibrillation in Older Adults
Fohtung, R. B., Novak, E. L., & Rich, M. W. (2017) · Journal of the American Geriatrics Society · doi:10.1111/jgs.15058 · Cited by 40
Wang, C., Wu, V. C., Lee, C., Kuo, C., Chen, Y., Chu, P., Chen, S., Wen, M., See, L., & Chang, S. (2018) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-018-1792-1 · Cited by 40
Eche, I. M., Elsamadisi, P., Wex, N., Wyers, M. C., Brat, G. A., Cunningham, K., & Bauer, K. A. (2019) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2306 · Cited by 40
Vitamin K Antagonists and Risk of Subdural Hematoma
Connolly, B. J., Pearce, L. A., & Hart, R. G. (2014) · Stroke · doi:10.1161/strokeaha.114.005430 · Cited by 39
Reinecke, H., Juergensmeyer, S., Engelbertz, C. M., Gerß, J., Kirchhof, P. F., BREITHARDT, G. E., Bauersachs, R. M., & Wanner, C. (2018) · BMJ Open · doi:10.1136/bmjopen-2018-022690 · Cited by 39
Self-citationMani, H., Herth, N., Kasper, A., Wendt, T. G., Schüttfort, G., Weil, Y., Pfeilschifter, W., Linnemann, B., Herrmann, E. M., & Lindhoff‐Last, E. (2014) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0000000000000064 · Cited by 38
Reduced Anticoagulant Effect of Dabigatran in a Patient Receiving Concomitant Phenytoin
Wiggins, B. S., Northup, A., Johnson, D., & Senfield, J. (2016) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1698 · Cited by 38
Okumura, K., Lip, G. Y. H., Akao, M., Tanizawa, K., Fukuzawa, M., Abe, K., Akishita, M., & Yamashita, T. (2017) · American Heart Journal · doi:10.1016/j.ahj.2017.08.017 · Cited by 38
Self-citationLee, S., Rhee, T., Kang, D., Choi, E., Oh, S., & Lip, G. Y. H. (2019) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2019.05.072 · Cited by 37
Self-citationThe Influence of Socioeconomic Status on Selection of Anticoagulation for Atrial Fibrillation
Sholzberg, M., Gomes, T., Juurlink, D. N., Yao, Z., Mamdani, M., & Laupacis, A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0149142 · Cited by 36
Ptacek, S. G., Escámez, B. C., Županič, E., Religa, D., von Koch, L., Johnell, K., von Euler, M., Kåreholt, I., & Eriksdotter, M. (2017) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2017.08.014 · Cited by 36
Noncardioembolic Stroke in Patients with Atrial Fibrillation
Katsi, V. K., Georgiopoulos, G. A., Skafida, A., Oikonomou, D., Klettas, D., Vemmos, K. N., & Tousoulis, D. (2018) · Angiology · doi:10.1177/0003319718791711 · Cited by 35
Kirchhof, P. F., Haas, S. K., Amarenco, P., Hess, S., Lambelet, M., van Eickels, M., Turpie, A. G. G., Camm, A. J., & the XANTUS Investigators* (2020) · Journal of the American Heart Association · doi:10.1161/jaha.118.009530 · Cited by 35
Self-citationNasser, M. F., Gandhi, S., Siegel, R. J., & Rader, F. (2020) · Heart Rhythm · doi:10.1016/j.hrthm.2020.09.018 · Cited by 35
Obesity and risk of bleeding: the SMART study.
Brækkan, S. K., van der Graaf, Y., Visseren, F. L. J., & Algra, A. (2015) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.13184 · Cited by 34
Mexican Americans With Atrial Fibrillation Have More Recurrent Strokes Than Do Non-Hispanic Whites
Simpson, J. R., Zahuranec, D. B., Lisabeth, L. D., Sánchez, B. N., Skolarus, L. E., Mendizabal, J. E., Smith, M. A., Garcia, N. M., & Morgenstern, L. B. (2010) · Stroke · doi:10.1161/strokeaha.110.589127 · Cited by 34
Moudallel, S., van den Bemt, B. J. F., Zwikker, H. E., de Veer, A., Rydant, S., van Dijk, L., & Steurbaut, S. (2020) · Patient Education and Counseling · doi:10.1016/j.pec.2020.06.016 · Cited by 34
Jacquemin, M. G., Toelen, J., Feyen, L., Schoeters, J., Horenbeeck, I. V., Vanlinthout, I., Debasse, M., Vanassche, T., Peerlinck, K., & Verhamme, P. B. (2018) · International Journal of Laboratory Hematology · doi:10.1111/ijlh.12807 · Cited by 33
Self-citationOutcomes associated with non-recommended dosing of rivaroxaban: results from the XANTUS study
Amarenco, P., Haas, S. K., Hess, S., Kirchhof, P. F., Lambelet, M., Bach, M., Turpie, A. G. G., & Camm, A. J. (2018) · European Heart Journal - Cardiovascular Pharmacotherapy · doi:10.1093/ehjcvp/pvy041 · Cited by 33
Self-citationMinno, A. D., Spadarella, G., Spadarella, E., Tremoli, E., & Minno, G. D. (2015) · Thrombosis Research · doi:10.1016/j.thromres.2015.10.016 · Cited by 32
Kawabori, M., Niiya, Y., Iwasaki, M., Mabuchi, S., Ozaki, H., Matsubara, K., & Houkin, K. (2018) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2017.12.020 · Cited by 32
Manohar, C. M., Avitsian, R., Lozano, S., Gonzalez-Martinez, J. A., & Cata, J. P. (2011) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2011.02.018 · Cited by 31
Lee, O., Kim, J., Pak, H., Hong, G., Shim, C. Y., Uhm, J., Cho, I., Joung, B., Yu, C. W., Lee, H., et al. (2018) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2018.02.045 · Cited by 31
Self-citationSanchis‐Gomar, F., Pérez-Quilis, C., & Lavie, C. J. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa509 · Cited by 31
Warfarin Users Prone to Coagulopathy in First 30 Days After Hospital Discharge from Gastric Bypass
Bechtel, P., Boorse, R., Rovito, P. F., Harrison, T. D., & Hong, J. J. (2013) · Obesity Surgery · doi:10.1007/s11695-013-0972-5 · Cited by 30
Warfarin Resistance After Total Gastrectomy and Roux‐en‐Y Esophagojejunostomy
Sobieraj, D. M., Wang, F., & Kirton, O. C. (2008) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.28.12.1537 · Cited by 30
Safouris, A., Demulder, A., Triantafyllou, N. I., & Tsivgoulis, G. K. (2014) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2014.09.008 · Cited by 30
Absence of Oral Anticoagulation and Subsequent Outcomes Among Outpatients with Atrial Fibrillation
Hess, P. L., Kim, S., Fonarow, G. C., Thomas, L. E., Singer, D. E., Freeman, J. V., Gersh, B. J., Ansell, J., Kowey, P. R., Mahaffey, K. W., et al. (2016) · The American Journal of Medicine · doi:10.1016/j.amjmed.2016.11.001 · Cited by 30
Anticoagulation for atrial fibrillation after intracranial hemorrhage
Hawkes, M. A., & Rabinstein, A. A. (2018) · Neurology Clinical Practice · doi:10.1212/cpj.0000000000000425 · Cited by 30
Genetic Polymorphisms Associated with Spontaneous Intracerebral Hemorrhage
Chen, Y., Chang, K., & Chen, C. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19123879 · Cited by 30
Walenga, J. M., Prechel, M., Hoppensteadt, D., Escalante, V., Chaudhry, T., Jeske, W. P., & Bakhos, M. (2013) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029613492876 · Cited by 29
Gennaro, L. D., Lancellotti, S., CRISTOFARO, R. D., & Candia, E. D. (2019) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-019-01866-1 · Cited by 29
Monitoring and reversal of direct oral anticoagulants
Cuker, A. C., & Siegal, D. M. (2015) · Hematology · doi:10.1182/asheducation.v2015.1.117.3916182 · Cited by 29
Duchin, K. L., Duggal, A., Atiee, G. J., Kidokoro, M., Takatani, T., Shipitofsky, N. L., He, L., Zhang, G., & Kakkar, T. (2017) · Clinical Pharmacokinetics · doi:10.1007/s40262-017-0554-0 · Cited by 28
Janion−Sadowska, A., Papuga-Szela, E., Łukaszuk, R., Chrapek, M., & Undas, A. (2018) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000607 · Cited by 28
Cannistraro, R. J., & Meschia, J. F. (2018) · Current Cardiology Reports · doi:10.1007/s11886-018-1052-1 · Cited by 28
Malik, A. H., Yandrapalli, S., Shetty, S. S., Aronow, W. S., Jain, D., Frishman, W. H., Cooper, H. A., Panza, J. A., & on behalf of MAGIC (Meta-analysis And oriGinal Investigations in Cardiology) Investigators (2019) · EP Europace · doi:10.1093/europace/euz361 · Cited by 28
Effectiveness and Safety of Direct Oral Anticoagulants in Relation to Temporal Changes in Their Use
Lee, S., Choi, E., Kwon, S., Jung, J., Han, K., Cha, M., Oh, S., & Lip, G. Y. H. (2020) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.119.005894 · Cited by 28
Self-citationLee, C., Lin, T., Chang, S., Chen, C.-H., Hsu, Y.-J., Hung, K., & Wen, M. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.11.277 · Cited by 27
Fanaroff, A. C., Steffel, J., Alexander, J. H., Lip, G. Y. H., Califf, R. M., & Lópes, R. D. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy236 · Cited by 27
Self-citationDelayed Intracranial Hemorrhage in Anticoagulated Geriatric Patients After Ground Level Falls
Cocca, A. T., Privette, A. R., Leon, S. M., Crookes, B., Hall, G. A., Lena, J., & Eriksson, E. A. (2019) · Journal of Emergency Medicine · doi:10.1016/j.jemermed.2019.09.011 · Cited by 27
Colonna, P., von Heymann, C., Santamaría, A., Saxena, M., Vanassche, T., Wolpert, D., Laeis, P., Wilkins, R. G., Chen, C. Y.-H., & Unverdorben, M. (2020) · Clinical Cardiology · doi:10.1002/clc.23379 · Cited by 27
Self-citationOkumura, K., Hori, M., Tanahashi, N., & Camm, A. J. (2016) · Clinical Cardiology · doi:10.1002/clc.22596 · Cited by 26
Self-citationSafety of Edoxaban 30 mg in Elderly Patients with Severe Renal Impairment
Fazio, G., Dentamaro, I., Gambacurta, R., Alcamo, P., & Colonna, P. (2018) · Clinical Drug Investigation · doi:10.1007/s40261-018-0693-6 · Cited by 26
Drug–drug interaction between levetiracetam and non-vitamin K antagonist anticoagulants
Mathy, F., Dohin, E., Bonfitto, F., & Pelgrims, B. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy780 · Cited by 26
Biffi, A., Urday, S., Kubiszewski, P. P., Gilkerson, L. A., Sekar, P., Rodriguez-Torres, A., Bettin, M., Charidimou, A., Pasi, M., Kourkoulis, C. E., et al. (2020) · Stroke · doi:10.1161/strokeaha.120.028310 · Cited by 26
Henrard, S., Vandenabeele, C., Marien, S., Boland, B. B., & Dalleur, O. (2017) · Drugs & Aging · doi:10.1007/s40266-017-0493-3 · Cited by 25
Bleeding in anticoagulated patients with atrial fibrillation: practical considerations
Undas, A., Drabik, L., & Potpara, T. (2020) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.15136 · Cited by 25
Self-citationUse of Stroke Secondary Prevention Services
Ross, J. S., Halm, E. A., & Bravata, D. M. (2009) · Stroke · doi:10.1161/strokeaha.108.539619 · Cited by 24
Acute Thrombocytopenia after Initiating Anticoagulation with Rivaroxaban
Mima, Y., Sangatsuda, Y., Yasaka, M., Wakugawa, Y., Nagata, S., & Okada, Y. (2014) · Internal Medicine · doi:10.2169/internalmedicine.53.2890 · Cited by 23
Gordon, L. A., Kumar, P., Brooks, K. M., Kellogg, A., McManus, M., Alfaro, R. M., Nghiem, K., George, J. M., Lozier, J. N., Penzak, S. R., et al. (2016) · Circulation · doi:10.1161/circulationaha.116.025257 · Cited by 23
The effect of apixaban on the pharmacokinetics of digoxin and atenolol in healthy subjects
Frost, C. E., Song, Y. J., Yu, Z., Wang, J. J. J., Lee, L., Schuster, A. E., Pollack, A., & LaCreta, F. P. (2017) · Clinical Pharmacology Advances and Applications · doi:10.2147/cpaa.s115687 · Cited by 23
Timing use of novel anti-epileptic drugs: is earlier better?
de Biase, S., Nilo, A., Bernardini, A., Gigli, G. L., Valente, M., & Merlino, G. (2019) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2019.1636649 · Cited by 23
Meinel, T. R., Frey, S., Arnold, M., Kendroud, S., Fischer, U., Kaesmacher, J., Heldner, M. R., & Jung, S. C. (2019) · PLoS ONE · doi:10.1371/journal.pone.0213379 · Cited by 22
Carotid Atherosclerosis in Patients with Atrial Fibrillation
Wang, Z., Korantzopoulos, P. G., & Liu, T. (2019) · Current Atherosclerosis Reports · doi:10.1007/s11883-019-0808-4 · Cited by 22
To measure or not to measure direct oral anticoagulants before surgery or invasive procedures: reply
Tripodi, A. (2016) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.13513 · Cited by 22
Li, H., Zhong, J.-Q., Zhang, W., Rong, B., Xie, F., Wang, J., Yue, X., Zheng, Z., Zhu, Q., & Zhang, Y. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.04.104 · Cited by 21
Apixaban in renal insufficiency: successful navigation between the Scylla and Charybdis
Steffel, J., & Hindricks, G. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs267 · Cited by 21
Self-citationImpact of the Direct Oral Anticoagulants on Activated Clotting Time
Dincq, A.-S., Lessire, S., Châtelain, B., Gourdin, M. J., Dogné, J., Mullier, F., & Douxfils, J. (2016) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2016.09.002 · Cited by 21
Favaloro, E. J., & Lippi, G. (2017) · PubMed · doi:10.2450/2017.0301-16 · Cited by 21
Lee, W., Fang, C.-Y., Chen, Y., Fang, H., Chen, H., Liu, W., Fu, M., & Chen, M. (2018) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2018.09.015 · Cited by 21
Schullo-Feulner, A. M., Stoecker, Z. R., Brown, G. A., Schneider, J., Jones, T. A., & Burnett, B. (2014) · Clinical Obesity · doi:10.1111/cob.12046 · Cited by 20
Determinants of medication adherence in older people with dementia from the caregivers’ perspective
El‐Saifi, N., Moyle, W., Jones, C., & Alston‐Knox, C. (2018) · International Psychogeriatrics · doi:10.1017/s1041610218000583 · Cited by 20
Goodman‐Casanova, J. M., Parra, J. G., Guerrero-Pertiñez, G., Vera, E., Barnestein‐Fonseca, P., Cortellessa, G., Fracasso, F., Umbrico, A., Cesta, A., Toma, D., et al. (2019) · BMC Geriatrics · doi:10.1186/s12877-019-1267-z · Cited by 20
Non-Traumatic Subdural Hemorrhage and Risk of Arterial Ischemic Events
Murthy, S. B., Wu, X., Diaz, I. M., Parasram, M., Parikh, N. S., Iadecola, C., Merkler, A. E., Falcone, G. J., Brown, S. C., Biffi, A., et al. (2020) · Stroke · doi:10.1161/strokeaha.119.028510 · Cited by 20
Non-Vitamin K Antagonist Oral Anticoagulant for Atrial Fibrillation in Obese Patients
Wang, S. Y., & Giugliano, R. P. (2020) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2020.04.016 · Cited by 20
Impacts of Different Renal Function Estimation Formulas on Dosing of DOACs and Clinical Outcomes
Chan, Y., Chao, T., Lee, H., Yeh, Y., Yeh, C., Huang, Y.-C., Chang, S., Kuo, C.-T., Lip, G. Y. H., & Chen, S. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.08.025 · Cited by 20
Self-citationExposure to CYP3A4‐inducing and CYP3A4‐non‐inducing antiepileptic agents and the risk of fractures
Schelleman, H., Pollard, J. R., Newcomb, C. W., Markowitz, C., Bilker, W. B., Leonard, M. B., & Hennessy, S. (2011) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.2141 · Cited by 19
Stöllberger, C., & Finsterer, J. (2014) · Heart & Lung · doi:10.1016/j.hrtlng.2014.03.004 · Cited by 19
Altman, R., & González, C. D. (2014) · Thrombosis Journal · doi:10.1186/1477-9560-12-7 · Cited by 19
Four-Factor Prothrombin Complex Concentrate for the Reversal of Direct Oral Anticoagulants
Zada, I., Wang, S., Akerman, M. B., & Hanna, A. F. (2019) · Journal of Intensive Care Medicine · doi:10.1177/0885066619882909 · Cited by 19
Emerging Role of Direct Oral Anticoagulants in the Management of Heparin-Induced Thrombocytopenia
Tran, P. N., & Tran, M. (2017) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029617696582 · Cited by 18
Edoxaban Versus Warfarin in Latin American Patients With Atrial Fibrillation
Corbalan, R. L., Nicolau, J. C., Lopez-Sendon, J. L., García-Castillo, A., Botero, R., Sotomora, G., Horna, M., Ruff, C. T., Hamershock, R. A., Grip, L. T., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.07.037 · Cited by 17
Microbleed prevalence and burden in anticoagulant‐associated intracerebral bleed
Lioutas, V., Goyal, N., Katsanos, A. H., Krogias, C., Zand, R., Sharma, V. K., Varelas, P. N., Malhotra, K., Paciaroni, M., Sharaf, A., et al. (2019) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.50834 · Cited by 17
Mazurek, M., Halperin, J. L., Huisman, M. V., Diener, H., Dubner, S., Sheng, C., Rothman, K. J., Healey, J. S., Teutsch, C., Paquette, M., et al. (2019) · EP Europace · doi:10.1093/europace/euz278 · Cited by 17
Self-citationon behalf of J-ELD AF investigators, Suzuki, S. S., Yamashita, T., Akao, M., & Okumura, K. (2020) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-020-02896-y · Cited by 16
Drug-induced thrombocytopenia after anticoagulation with rivaroxaban
Pop, M. K., Farokhi, F., & Iduna, L. (2017) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2017.12.052 · Cited by 15
Ge, Z., Faggioni, M., Baber, U., Sartori, S., Sorrentino, S., Farhan, S., Chandrasekhar, J., Vogel, B., Qadeer, A., Halperin, J. L., et al. (2018) · Cardiovascular Therapeutics · doi:10.1111/1755-5922.12457 · Cited by 15
Acton, E. K., Willis, A. W., Gelfand, M. A., & Kasner, S. E. (2019) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.4896 · Cited by 15
von Oertzen, T. J., Trinka, E., & Bornstein, N. M. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz657 · Cited by 15
Kwon, S., Lee, S., Choi, E., Choe, W.-S., Lee, E., Jung, J., Han, K., Oh, S., & Lip, G. Y. H. (2020) · American Heart Journal · doi:10.1016/j.ahj.2020.08.006 · Cited by 15
Self-citationMicrobleeds in ischemic vs hemorrhagic strokes on novel oral anticoagulants
Purrucker, J. C., Wolf, M., Haas, K., Siedler, T., Rizos, T., Khan, S., Heuschmann, P. U., Veltkamp, R. C., & the RASUNOA Investigators (2018) · Acta Neurologica Scandinavica · doi:10.1111/ane.12934 · Cited by 14
Taha, M., Li, W., Schmidt, C., Gonzalez‐Castellon, M., & Taraschenko, O. D. (2020) · Epilepsy Research · doi:10.1016/j.eplepsyres.2020.106304 · Cited by 14
Soo, Y. O. Y., Abrigo, J., Leung, K. T., Liu, W., Lam, B. Y. K., Tsang, S. F., Ip, V. H. L., Ma, K., Ip, B. Y. M., Ma, S. H., et al. (2018) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2017-317151 · Cited by 13
Xing, L. Y., Barcella, C. A., Sindet‐Pedersen, C., Bonde, A. N., Gislason, G., & Olesen, J. B. (2019) · Thrombosis Research · doi:10.1016/j.thromres.2019.04.007 · Cited by 13
Pazan, F., Collins, R., Gil, V. M., Hanon, O., Hardt, R., Hoffmeister, M., Monteiro, P. F., Quinn, T. J., Ropers, D., Sergi, G., et al. (2020) · Drugs & Aging · doi:10.1007/s40266-020-00771-0 · Cited by 13
Self-citationEfficacy and safety of dabigatran versus warfarin from the RE-LY trial
Avezum, Á., Oliveira, G. B. D. F., Díaz, R., Hermosillo, J. A. G., Oldgren, J., Ripoll, E. F., Noack, H., Piegas, L. S., & Connolly, S. J. (2018) · Open Heart · doi:10.1136/openhrt-2018-000800 · Cited by 12
Self-citationThrombocytopenia induced by dabigatran: two case reports
Kang, H. G., Lee, S. J., Chung, J. Y., & Cheong, J. S. (2017) · BMC Neurology · doi:10.1186/s12883-017-0900-8 · Cited by 11
Lu, V. M., Phan, K. H., Rao, P. J., Sharma, S. V., & Kasper, E. M. (2019) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2019.04.013 · Cited by 11
Nguyen, N. Y., & Frishman, W. H. (2020) · Cardiology in Review · doi:10.1097/crd.0000000000000288 · Cited by 11
Escudero‐Martínez, I., Mazya, M. V., Teutsch, C., Leško, N., Gdovinová, Z., Barbarini, L., Fryze, W., Karlinski, M. A., Kobayashi, A., Krastev, G., et al. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-037234 · Cited by 11
Clinically relevant interaction of rivaroxaban and valproic acid – A case report
Langenbruch, L. M., Meuth, S. G., Wiendl, H., Mesters, R. M., & Möddel, G. (2020) · Seizure · doi:10.1016/j.seizure.2020.05.024 · Cited by 11
Acute thrombocytopenia after anticoagulation with rivaroxaban: A case report
He, X.-Y., & Bai, Y. (2020) · World Journal of Clinical Cases · doi:10.12998/wjcc.v8.i5.928 · Cited by 10
Chan, L. (2014) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1417 · Cited by 9
Case report: apixaban‐induced thrombocytopenia
Snellgrove, O. (2017) · Clinical Case Reports · doi:10.1002/ccr3.809 · Cited by 9
Corbalan, R. L., Conejeros, C., Rey, C., Stockins, B., Germán Eggers, R., Astudillo, C., Lanas, F. T., Potthoff, S., Houzvic, C., Montecinos, H., et al. (2017) · Revista médica de Chile · doi:10.4067/s0034-98872017000800963 · Cited by 8
Yang, Y.-K., Du, X., Dong, J., & Ma, C. (2019) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2019.07.013 · Cited by 8
Thrombocytopenia: A possible side effect of apixaban
Sadaka, F. G. (2019) · Clinical Case Reports · doi:10.1002/ccr3.2532 · Cited by 8
Steffel, J., & Potpara, T. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy784 · Cited by 6
Self-citationStroke prevention in AF: Of Asians and non-Asians
Steffel, J., & Eikelboom, J. W. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy776 · Cited by 4
Self-citationSteffel, J. (2020) · European Heart Journal Supplements · doi:10.1093/eurheartj/suaa102 · Cited by 4
Self-citationBleeding in anticoagulated patients with atrial fibrillation: practical considerations
Undas, A., Drabik, L., & Potpara, T. (2020) · Kardiologia Polska · doi:10.33963/kp.15218 · Cited by 4
Self-citationNet clinical benefit of anticoagulation for atrial fibrillation following intracerebral hemorrhage
Pappas, M. A., & Burke, J. F. (2020) · Vascular Medicine · doi:10.1177/1358863x19883027 · Cited by 3
Safety of Apixaban Administered via Nasogastric Tube
O'Dell, K. B., & Costello, J. (2019) · Cardiology · doi:10.1159/000495577 · Cited by 2
Potpara, T., & Steffel, J. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz659 · Cited by 2
Self-citation
Flagged first, then by citations
2 of the 558 references couldn’t be matched to a known paper.
Research works printed but not linked: 2
- Corbalan, 2017, [Features, management and prognosis of Chilean patients with non valvular atrial fibrillation: GARFIELD AF registry], Rev Med Chil, 145, 963
- Kubitza, 2006, No interaction between the novel, oral direct factor Xa inhibitor BAY 59-7939 and digoxin, J Clin Pharmacol, 46, 702
Cited by
Sorted by citations
Lyon, A. R., López‐Fernández, T., Couch, L. S., Asteggiano, R., Aznar, M. C., Bergler-Klein, J. K., Boriani, G., Cardinale, D. M., Córdoba, R., Cosyns, B., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac244 · Cited by 3,457
Self-citationGelder, I. C. V., Rienstra, M., Bunting, K. V., Casado-Arroyo, R., Caso, V., Crijns, H. J. G. M., Potter, T. J. R. D., Dwight, J., Guasti, L., Hanke, T., et al. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae176 · Cited by 3,507
Self-citation2024 ESC Guidelines for the management of chronic coronary syndromes
Vrints, C. J., Andreotti, F., Koskinas, K. C., Rosselló, X., Adamo, M., Ainslie, J., BANNING, A. P., Budaj, A., Buechel, R. R., Chiariello, G. A., et al. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae177 · Cited by 3,521
Halvorsen, S., Mehilli, J., Cassese, S., Hall, T. S., Abdelhamid, M., Barbato, E., Hert, S. G. D., de Laval, I., Geisler, T., Hinterbuchner, L., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac270 · Cited by 1,287
Self-citationTzeis, S. E., Gerstenfeld, E. P., Kalman, J. M., Saad, E., Shamloo, A. S., Andrade, J. G., Barbhaiya, C. R., Baykaner, T., Bovéda, S., Calkins, H. G., et al. (2024) · EP Europace · doi:10.1093/europace/euae043 · Cited by 724
Self-citation
Metadata
- Authors
- Steffel, J., Collins, R., Antz, M., Cornu, P., Desteghe, L., Haeusler, K. G., Oldgren, J., Reinecke, H., Roldan-Schilling, V., Rowell, N., Sinnaeve, P., Vanassche, T., Potpara, T., Camm, A. J., Heidbüchel, H., reviewers, E., Lip, G. Y. H., Deneke, T., Dagres, N., Boriani, G., Chao, T.-F., Choi, E.-K., Hills, M. T., Santos, I. D. S., Lane, D. A., Atar, D., Joung, B., Cole, O. M., & Field, M.
- Affiliations
- University of Zurich (CH)
- Age-Related Health Care, Tallaght University Hospital / Department of Gerontology Trinity College , Dublin,
- Klinikum Braunschweig (DE)
- Vrije Universiteit Brussel (BE)
- University of Antwerp (BE)
- Department of Neurology, Universitätsklinikum Würzburg , Würzburg,
- Uppsala University (SE)
- University Hospital Münster (DE)
- University of Murcia , Murcia,
- Middlesbrough ,
- KU Leuven (BE)
- University of Belgrade (RS)
- St George's, University of London (GB)
- University of Liverpool (GB)
- Rhön-Klinikum (DE)
- University of Modena and Reggio Emilia (IT)
- Seoul National University (KR)
- Universidade de São Paulo (BR)
- Centro de Pesquisa Clínica e Epidemiológica, Hospital Universitário, Universidade de São Paulo , São Paulo,
- Oslo University Hospital (NO)
- Corresponding author
- Steffel, Jan
- ORCID
- Venue
- EP Europace
- Publisher
- Oxford University Press (OUP)
- Published
- 2021-04-25
- Volume
- 23
- Issue
- 10
- Pages
- 1612-1676
- ISSN
- 1099-5129 (ISSN-L)
- 1532-2092
- PMC
- PMC11636576
- OpenAlex
- W3159673032
- Cited by
- 1,132
- References
- 558
- Citations by year
- 2026: 148 · 2025: 179 · 2024: 228 · 2023: 269 · 2022: 224 · 2021: 83
- FWCI
- 134.75
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- EP Europace (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- St George's Online Research Archive (St George's University of London) (acceptedVersion)
- Document Server@UHasselt (UHasselt) (submittedVersion)
- YUHSpace (Yonsei University Medical Library) (submittedVersion, cc-by-nc-nd)
- IRIS UNIMORE (University of Modena and Reggio Emilia) (submittedVersion, cc-by)
- Lirias (submittedVersion)
- VBN Forskningsportal (Aalborg Universitet) (submittedVersion)
- VUBIR (Vrije Universiteit Brussel) (submittedVersion)
- Funders
- Bayer Pharma AG
- Bristol-Myers Squibb
- Pfizer Alliance
- Daiichi-Sankyo Europe GmbH
- NIH
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
- Health Sciences › Medicine › Internal Medicine › Venous Thromboembolism Diagnosis and Management
- Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
- Keywords
- direct oral anticoagulants, atrial fibrillation, coronary artery disease, cardioversion, acute stroke, old age, frailty, stroke prevention
- MeSH terms
- Rivaroxaban, Dabigatran, Administration, Oral, Anticoagulants, Atrial Fibrillation, Humans, Pyridones, Stroke
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
